WebApr 11, 2024 · Immunological data from recently completed Phase 1b trial will be presented on April 16 th. PLYMOUTH MEETING, Pa., April 12, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer, and … WebAug 9, 2024 · INOVIO's management will host a live conference call and webcast at 4:30 p.m. Eastern Time today to discuss financial results and provide a general business update.
Inovio Pharmaceuticals - INO Stock Forecast, Price & News
WebMar 6, 2024 · Inovio Pharmaceuticals, Inc. (NASDAQ: INO) Q4 2024 Earnings Call Transcript March 1, 2024 Operator: Good afternoon, and welcome to the Inovio Pharmaceuticals Fourth Quarter 2024 Financial... WebNov 8, 2024 · Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 08, 2024, 4:30 p.m. ET Contents: Prepared Remarks Questions and Answers Call Participants … ez kexa vetements
Inovio Pharmaceuticals, Inc. (INO) Q3 2024 Earnings Call Transcript
Web4 rows · Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings ... WebMar 1, 2024 · Thanks, Joseph, and good afternoon, everyone. We ended the fourth quarter with $401.3 million in cash, cash equivalents and short term investments compared to $411.6 million as of December 31 ... WebMar 1, 2024 · Inovio Pharmaceuticals, Inc. - INOVIO Reports Fourth Quarter 2024 and Year-End Financial Results INVESTORS & MEDIA News Details View all news INOVIO Reports Fourth Quarter 2024 and Year-End Financial Results March 01, 2024 Download Investor … At INOVIO, we promise to treat your data with respect and will not share your … Disease Program Study Phase Summary; DiseaseBRCA1/2 Mutation Carriers (More … Ms. Gevgilili joins INOVIO from Allergan (acquired by AbbVie), where she spent … ezkey electronics